US11040139B2ActiveUtilityPatentIndex 62
Drug delivery systems with sealed and sterile fluid paths and methods of providing the same
Est. expiryNov 11, 2036(~10.4 yrs left)· nominal 20-yr term from priority
Inventors:MCLAUGHLIN IAN
A61L 2103/23A61L 2/206A61M 5/162A61L 2/081A61L 2/082A61L 2/087A61L 2/07A61M 5/16827A61M 5/001A61M 5/2466A61L 2/00A61M 2005/3118A61M 2039/1072A61M 2005/3132A61M 2005/3258A61M 5/19A61M 5/14566A61L 2202/23
62
PatentIndex Score
0
Cited by
48
References
20
Claims
Abstract
The present disclosure relates generally to the field of drug delivery. In particular, the present disclosure relates to a drug delivery system that includes a sealed and sterile fluid path attached to a drug-loaded container. The disclosure further relates to methods for sterilizing a portion of the drug delivery system without exposing the drug-loaded container to harmful sterilization parameters.
Claims
exact text as granted — not AI-modifiedThe invention claimed is:
1. A method, comprising:
providing an energy source and a drug delivery system; and
positioning a shield between the energy source and the drug delivery system, the drug delivery system comprising a container, a fluid path, and a cover, wherein the container holds a liquid drug, wherein a first end of the fluid path is disposed within the container, and wherein a second end of the fluid path is disposed within the cover.
2. The method of claim 1 , further comprising:
emitting energy from the energy source;
sterilizing the fluid path by exposing the fluid path to the energy emitted by the energy source; and
blocking exposure of the liquid drug to a substantial portion of the energy emitted by the energy source.
3. The method of claim 2 , further comprising sterilizing the liquid drug prior to sterilizing the fluid path.
4. The method of claim 1 , wherein positioning the shield comprises positioning an aluminum shield having a thickness of at least 30 mm between the drug delivery system and the energy source.
5. The method of claim 1 , further comprising piercing a cap sealing the container with the first end of the fluid path to couple the liquid drug to the fluid path.
6. The method of claim 1 , further comprising piercing a septum sealing the container with the first end of the fluid path to couple the liquid drug to the fluid path.
7. The method of claim 1 , further comprising piercing a plunger sealing the container with the first end of the fluid path to couple the liquid drug to the fluid path.
8. The method of claim 1 , wherein positioning the shield comprises placing the fluid path and the container within a first shield component having an exposure window and coupling a second shield component to the first shield component.
9. A method for sterilizing a liquid drug in a drug delivery system, comprising:
positioning a shield between an energy source and the drug delivery system, the drug delivery system comprising a fluid path and a container holding the liquid drug; and
exposing the fluid path to an energy emitted by the energy source, wherein the shield blocks exposure of the liquid drug to at least a portion of the energy.
10. The method of claim 9 , further comprising sterilizing the liquid drug prior to sterilizing the fluid path.
11. The method of claim 9 , wherein positioning the shield comprises positioning an aluminum shield having a thickness of at least 30 mm between the drug delivery system and the energy source.
12. The method of claim 9 , further comprising piercing a cap sealing the container with the fluid path to couple the liquid drug to the fluid path upon activation by a user.
13. The method of claim 9 , further comprising piercing a septum sealing the container with the fluid path to couple the liquid drug to the fluid path upon activation by a user.
14. The method of claim 9 , further comprising piercing a plunger sealing the container with the fluid path to couple the liquid drug to the fluid path upon activation by a user.
15. The method of claim 9 , wherein positioning the shield comprises placing the fluid path and the container within a first shield component having an exposure window and coupling a second shield component to the first shield component.
16. A method, comprising:
positioning a shield between an energy source and a drug delivery system, the drug delivery system comprising a fluid path for accessing a liquid drug within a container; and
exposing the fluid path to an energy emitted by the energy source, wherein the shield blocks exposure of the liquid drug to at least a portion of the energy.
17. The method of claim 16 , further comprising blocking exposure, by the energy emitted from the energy source, of an entire portion of the container and at least a portion of a cap inserted within the container.
18. The method of claim 17 , further comprising piercing the cap with the fluid path to couple the liquid drug to the fluid path upon activation by a user.
19. The method of claim 16 , further comprising exposing an entire portion of the fluid path to the energy emitted by the energy source.
20. The method of claim 16 , wherein positioning the shield comprises placing the fluid path and the container within a first shield component having an exposure window and coupling a second shield component to the first shield component.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.